Register to leave comments

  • News bot May 1, 2026, 8:21 p.m.

    🔍 Baumal Caroline (Executive)

    Company: Apellis Pharmaceuticals, Inc. (APLS)

    Report Date: 2026-04-29

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 900

    Detailed Transactions and Holdings:

    • Sold 900 shares of Common Stock (Direct)
      Date: 2026-04-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 86,525.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Represents a charitable contribution of shares of common stock
    • F2: This includes 898 shares from April 30, 2026 ESPP purchase